Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

3.2K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.2K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

1.2K
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.2K
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

1.3K
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

440
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
440
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

512
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
512
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

2.1K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

False positive serum vascular endothelial growth factor-D in a patient with Birt-Hogg-Dubé syndrome.

Respiratory medicine case reports·2026
Same author

Immediate versus conventional loading implants with fixed prosthesis - A clinical and radiological study.

Bioinformation·2026
Same author

Diffuse Alveolar Hemorrhage in Lymphangioleiomyomatosis.

Chest·2026
Same author

Assessment of the Accuracy of Clear Aligner Therapy for Maxillary Expansion: A Prospective Clinical Study.

Clinical, cosmetic and investigational dentistry·2026
Same author

Feasibility and reliability of home spirometry in lymphangioleiomyomatosis.

Annals of the American Thoracic Society·2026
Same author

Hyperactivation of mTORC1 signaling mediates folliculin deficiency-induced pulmonary cyst formation in Birt-Hogg-Dubé syndrome.

The Journal of clinical investigation·2026

Related Experiment Video

Updated: Apr 21, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

7.9K

Pharmacotherapy in the cardiac catheterization laboratory: evolution and recent developments.

Guramrinder S Thind1, Raunak Parida1, Nishant Gupta2

  • 1SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India.

Therapeutics and Clinical Risk Management
|November 4, 2014
PubMed
Summary

New antiplatelet and anticoagulant drugs have transformed acute coronary syndrome and cardiac catheterization management. This review analyzes current evidence on novel antithrombotics to aid clinical decision-making.

Keywords:
acute coronary syndromeanticoagulantsantiplateletspercutaneous coronary intervention

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

7.7K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

14.9K

Related Experiment Videos

Last Updated: Apr 21, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

7.9K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

7.7K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

14.9K

Area of Science:

  • Cardiology
  • Pharmacology
  • Thrombosis Research

Background:

  • Significant advancements in antithrombotic therapies have occurred since 2000, with nine new drugs approved by the FDA.
  • Dual antiplatelet therapy (DAPT) is a cornerstone in managing acute coronary syndrome (ACS) and post-cardiac catheterization.
  • Clopidogrel is a widely used P2Y12 inhibitor, but newer agents like prasugrel and ticagrelor offer alternatives.

Purpose of the Study:

  • To review and analyze current evidence on novel antiplatelet and anticoagulant drugs.
  • To integrate pharmacological and clinical data for a comprehensive understanding of drug efficacy and safety.
  • To assist clinicians in making informed therapeutic decisions for patients requiring antithrombotic therapy.

Main Methods:

  • Literature search of high-impact clinical trials, pharmacological studies, meta-analyses, and reviews.
  • Utilized the MEDLINE database for evidence retrieval.
  • Employed an interdisciplinary approach combining pharmacological and clinical data.

Main Results:

  • Multiple novel P2Y12 inhibitors (prasugrel, ticagrelor) and anticoagulants (enoxaparin, bivalirudin) have been extensively studied and compared to established therapies.
  • The role of glycoprotein IIb/IIIa inhibitors is evolving.
  • Numerous drugs targeting novel pathways are under investigation.

Conclusions:

  • Recent innovations have expanded therapeutic options for managing thrombotic conditions.
  • Evidence-based analysis of these agents is crucial for optimizing patient care.
  • Further research into novel antithrombotics will continue to refine treatment strategies.